SCHEMBL7498518

SCHEMBL7498518

N#Cc1ccc2nc(Cl)nc(NCc3ccc4nc[nH]c4c3)c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 13/20 0.45
BCDIN3D Q7Z5W3 1/20 0.44
HRH4 Q9H3N8 1/20 0.43
APP P05067 1/20 0.42
CDK1 P06493 2/20 0.41
CCNC P24863 1/20 0.40
CDKN1A P38936 1/20 0.40
CDK8 P49336 1/20 0.40
CDK19 Q9BWU1 1/20 0.40
TMIGD3 P0DMS9 1/20 0.40
HTR2C P28335 1/20 0.40
HTR2B P41595 1/20 0.40
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7498511 0.93 PDE5A (0.44) PDE5AHRH4APPCDK1CCNC
SCHEMBL7491288 0.86 TMIGD3 (0.48) PDE5ABCDIN3DHRH4APPTMIGD3
SCHEMBL7503174 0.84 PDE5A (0.62) PDE5ACDK1CCNCCDKN1ACDK8
SCHEMBL7498135 0.82 CNR1 (0.46) PDE5ABCDIN3DHRH4CDK1
SCHEMBL7491271 0.78 TMIGD3 (0.47) PDE5ABCDIN3DHRH4APPTMIGD3
SCHEMBL7495253 0.78 PDE4A (0.53) PDE5AHRH4CDK1
SCHEMBL7492759 0.77 PDE5A (0.71) PDE5AALDH1A1TSHRCLK4
SCHEMBL7494193 0.77 PDE5A (0.70) PDE5A
SCHEMBL7503167 0.77 PDE5A (0.61) PDE5ACDK1CCNCCDKN1ACDK8
SCHEMBL8863020 0.77 HTR2C (0.46) PDE5ABCDIN3DAPPCDK1TMIGD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607439-B1 NITROGENOUS HETEROCYCLIC COMPOUND EISAI CO LTD (JP) 2002-01-09 EP disclosed
US-6046206-A Method of treating a patient having a precancerous lesions with amide quinazoline derivatives CELL PATHWAYS, INC. (US) 2000-04-04 US disclosed
US-5801180-A ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS EISAI CO., LTD. (JP) 1998-09-01 US disclosed
US-5693652-A Benzimidazoles for ischemic heart conditions EISAI CO., LTD. (JP) 1997-12-02 US disclosed
US-5576322-A Anti-ischemic 2,4-diaminoquinazolines EISAI CO., LTD. (JP) 1996-11-19 US disclosed
EP-0607439-A1 NITROGENOUS HETEROCYCLIC COMPOUND Eisai Co., Ltd. (JP) 1994-07-27 EP disclosed